Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Klencke Barbara
Relationship:   Director
City:   Vancouver
State:   A1
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   50,986    

Indirect Shares

  25,000      
Direct Value   $125,826    

Indirect Value

  $0      
Total Shares   75,986      
Total Value   $125,826      


Tscan Therapeutics, Inc.
 $0 Xencor Inc
 $125,826 Tscan Therapeutics, Inc.
 $0 Xencor Inc
 $125,826
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Sierra Oncology Inc SRRA Chief Medical Officer 2022-07-01 0 2022-07-01 0    Premium*  
            Tscan Therapeutics, Inc. TCRX 2024-09-23 45,000 2024-09-23 25,000    Premium*  
            Xencor Inc XNCR Director 2024-06-13 5,986 2024-06-13 0    Premium*  
* Premium Members only  

Records found :    14         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
SRRA Sierra Oncology Inc Chief Medical Officer   •       –      –    2022-07-01 4 D $55.00 $550,000 D/D (10,000) 0 0 -
SRRA Sierra Oncology Inc Chief Medical Officer   •       –      –    2022-07-01 4 D $55.00 $275,000 I/I (5,000) 0 0 -
SRRA Sierra Oncology Inc Chief Development Officer   •       –      –    2020-08-18 4 B $12.25 $40,738 I/I 3,325 5,000 1.99 -
XNCR Xencor Inc Director   •       •      –    2024-06-13 4 A $0.00 $0 D/D 5,986 5,986 0 -
SRRA Sierra Oncology Inc Chief Development Officer   •       –      –    2020-08-18 4 B $12.22 $72,710 D/D 5,950 10,000 2.74 -
TCRX Tscan Therapeutics, Inc. Director   –       •      –    2023-04-06 3 IO $0.00 $0 I/I 0 25,000 -
TCRX Tscan Therapeutics, Inc. Director   –       •      –    2023-04-06 3 IO $0.00 $0 D/D 0 25,000 -
TCRX Tscan Therapeutics, Inc.   –       •      –    2023-12-14 4 B $5.08 $25,400 D/D 5,000 30,000 0.01 -
TCRX Tscan Therapeutics, Inc.   –       •      –    2024-08-23 4 B $5.69 $28,450 D/D 5,000 35,000 0.01 -
TCRX Tscan Therapeutics, Inc.   –       •      –    2024-08-26 4 B $5.53 $27,650 D/D 5,000 40,000 0.01 -
TCRX Tscan Therapeutics, Inc.   –       •      –    2024-09-23 4 B $5.29 $26,450 D/D 5,000 45,000 0.01 -
SRRA Sierra Oncology Inc Chief Development Officer   •       –      –    2019-08-22 4 B $0.45 $24,295 D/D 54,000 54,000 2.74 -
SRRA Sierra Oncology Inc Chief Development Officer   •       –      –    2019-08-22 4 B $0.43 $28,964 I/I 67,000 67,000 1.99 -
SRRA Sierra Oncology Inc Chief Development Officer   •       –      –    2019-08-23 4 B $0.44 $47,380 D/D 108,000 162,000 2.74 -

  14  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed